European Archives - Page 513 of 1012 - European Medical Journal

Cytokine Storm Criteria Enable Early COVID-19 Diagnosis

CYTOKINE storm is the term given to immune responses triggered by escalated infections, such as in the coronavirus disease (COVID-19). Severe immune…

Joining forces with the NHS

With a focus on open channels of communication, pharma and the NHS have the potential not just to survive, but to truly thrive.

Q&A Webinar on the Management of Recurrent Cystitis

The aim of this webinar is to share highlights on the topic “Improving the management of recurrent cystitis in clinical practice: can we do more?”…

The road to representative trial recruitment

Achieving equal and accurate representation in clinical trials has long been a challenge for the pharmaceutical industry. We have made great progress towards the goal of patient inclusivity, but what more can be done to ensure that all patient groups are adequately represented and how can digital help to achieve this?

Pfizer's Mace Rothenberg on his passion for advancing oncology

Mace Rothenberg, Chief Medical Officer, Pfizer, speaks to us about his sustained passion for advancing the field of oncology, the importance of diverse representation in patient groups, and the challenges of balancing lifespan with health span.

Is pharma recession-proof?

How ‘recession-proof’ is pharma, and what challenges has COVID-19 posed to this famously robust industry?

The fight against the superbugs

How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?

Picking the perfect campaign star

Celebrity endorsements can transform a mediocre pharma campaign into a pitch-perfect hit, but choosing the right spokesperson is crucial. We explore the practice of attaching famous faces to campaigns and how to ensure a representative strikes the right chord

Talking to Patrick Romano

Patrick Romano, Co-founder and Partner, Eradigm Consulting, talks about his experience as a biochemist, how to build pharmaceutical value propositions fit for the future, and how the industry can navigate the blurring of lines between pharma and public health.

EMJ Respiratory 8.1 2020 Feature Image

EMJ Respiratory 8.1 2020

EMJ Respiratory features an impressive collection of new and fascinating research, alongside our independent review of the virtual European Respiratory Society (ERS) International Congress 2020 with research and breaking news from the virtual event.